Cara Therapeutics, Inc. (CARA) earnings
Quarterly and annual CARA reports and results, each read against the price at its own news timestamp. Back to the CARA overview →
10 measured CARA earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Tvardi Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-K Cara Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -1.73% | |
| Form 10-Q Cara Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.41% | -2.87% | |
| Form 10-Q Cara Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -1.81% | |
| Cara Therapeutics Reports First Quarter 2024 Financial Results | Press release | -4.14% | -4.98% | |
| Form 10-Q Cara Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -4.14% | -4.98% | |
| Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024 | Press release | -0.59% | +0.69% | |
| Cara Therapeutics Reports Third Quarter 2023 Financial Results | Press release | -11.11% | -6.41% | |
| Form 10-Q Cara Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -11.11% | -6.41% | |
| Cara Therapeutics to Announce Third Quarter 2023 Financial Results on November 13, 2023 | Press release | -3.08% | -5.38% |
Keep exploring
More CARA: analyst actions → · SEC filings → · CARA overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Patterson Companies, Inc. (PDCO) | 144 | 0.00% | 48% |
| Propanc Biopharma, Inc. (PPCB) | 144 | 0.00% | 41% |
| Nutriband Inc. (NTRB) | 143 | 0.00% | 44% |
| Redhill Biopharma Ltd. - American Depositary Shares (RDHL) | 143 | -0.50% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.